Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 1 OF 7 | DISPLAYING 1 - 15 OF 92 RESULTS

    Oberkampf M. et. al., 2018 Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells, https://doi.org/10.1038/s41467-018-04686-8, Nature Commun., Jun 08, 2018

    Cheung P.F-Y. et. al., 2018 Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targeting, .1158/0008-5472.CAN-18-0052, Cancer Res., May 29, 2018

    Chen M. et. al., 2018 JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer, https://doi.org/10.1016/j.clbc.2018.05.006, Clin. Breast Can., May 26, 2018

    Noh K.W et. al., 2018 Integrin β3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged NSCLC., 10.1158/1078-0432.CCR-17-3492. , Clin. Can Res., May 18, 2018

    Chettimada S. et. al., 2018 Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy, https://doi.org/10.1038/s41598-018-25515-4, Sci. Reports, May 08, 2018

    Zhang A.W. et. al., 2018 Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer., 10.1016/j.cell.2018.03.073., Cell, May 07, 2018

    Liu Z. et. al., 2018 Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients., 10.1158/1078-0432.CCR-17-1350, Clin. Can. Res,, Apr 30, 2018

    Ganguly D. et. al., 2018 The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma, 10.18632/oncotarget.25188, Oncotarget, Apr 24, 2018

    Mu L. et. al., 2018 The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas, 10.3389/fnmol.2018.00082, Front. Mol. Neurosci., Mar 28, 2018

    Wielgos M.E. et. al., 2018 Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition., 10.1158/1535-7163.MCT-17-0302, Mol. Cancer. Ther., Mar 28, 2018

    Arend R.C. et. al., 2018 Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma., 10.1158/1541-7786.MCR-17-0594, Mol. Can. Res., Mar 08, 2018

    Nakazawa Y. et. al., Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer, 10.1038/s41598-018-22340-7, Sci. Reports, Mar 05, 2018

    Zamarin D. et. al., 2018 PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy, 10.1172/JCI98047 , JCI, Mar 05, 2018

    Sampath S. et. al., Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients, 10.18632/oncotarget.24397 , Oncotarget, Feb 02, 2018

    Daemen A. et. al., HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors, 10.1186/s13058-018-0933-y, Breast Can. Res., Jan 30, 2018